Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 

Newsletter May 2018

genetherapynetbanner468x60
News: A Harvard startup is using gene therapy to reverse ageing in dogs, humans are next
In order to achieve the objective to “have the body and mind of a 22-year-old but the experience of a 130-year-old,” a Harvard professor backed startup is planning to rejuvenate dogs using gene therapy. And, if results are positive, the same approach could be used in humans. Rejuvenate Bio, co-founded by George Church of Harvard Medical School, has already carried out age-defying tests on beagles and claims it will make animals “younger" by adding new DNA instructions to their bodies.
Read more...

News: Latest Up and Coming Gene Therapies
Gene therapy’s numbers look promising. In a year full of biopharma mergers and acquisitions, one of the biggest deals has been Novartis’ planned $8.7 billion purchase of AveXis, whose lead candidate AVXS-101 has advanced into a pivotal trial following positive Phase I data published in November in The New England Journal of Medicine. Additional figures furnished to GEN by Informa show the extent of gene-therapy development: Informa Pharma Intelligence’s Trialtrove database records 729 gene therapies as having been developed, of which nearly two-thirds (461) were preclinical. Those therapies have been assessed in 1,855 clinical trials, most in early phases: 657 in Phase I, 509 in Phase I/II, and 455 in Phase II. As for later development, 89 have reached Phase III, 32 are in Phase II/III, and 28 in Phase IV.
Read more...

News: Gene therapy for beta-thalassemia safe, effective in people
In a powerful example of bench-to-bedside science showing how observations made in the lab can spark life-altering therapies in clinic, an international team of clinician-investigators has announced that gene therapy for patients with a severe form of the blood disorder beta-thalassemia can be safe and effective. Led by study director Philippe Leboulch, MD, a sponsored collaborator in Brigham and Women's Hospital's Division of Genetics and lecturer in medicine at Harvard Medical School, the research team reports that a one-time treatment with the gene therapy known as LentiGlobin BB305 vector reduced or eliminated the need for blood transfusions in 22 patients with severe beta-thalassemia. The team's results are published in the April 19 issue of The New England Journal of Medicine.
Read more...

Conference: Advanced Therapy Medicinal Products conference
This year, the Parenteral Drug Association celebrates on 5-6 June 2018 the 10th Anniversary of the Advanced Therapy Medicinal Products conference at the Novotel Amsterdam Schiphol Airport in Amsterdam. PDAs ATMPs conference has become a fixture in the calendar for all professionals working in the field of cell and gene-therapy-based drug products. PDA invites representatives from industry, research organizations and regulatory authorities to discuss the many challenges involved in the development, testing, production and registration of ATMPs.
Use the code GENE_AMS_18 to redeem 20% discount.

Read more...

Conference: CAR-TCR Summit Asia
The CAR-TCR Summit Asia, 27-28 June 2018, Singapore, is dedicated to the global delivery of safe, effective & commercially successful CAR-T and TCR cell therapies for liquid & solid tumor indications.
As the commercialization and approval of CAR-T therapies continues to gain momentum, the leaders are working to globalize the delivery of “curative” CAR-T and TCR therapies to beyond the Western world. Asia, as one of the world’s largest economies will serve as a cornerstone for the development and delivery of novel cellular immunotherapies.
The CAR-TCR Summit Asia is the dedicated platform focused on ensuring the clinical translation of CAR-T and TCR therapies to the market globally, ensuring affordability and accessibility to all those in need.

Read more...

Conference: The Bioprocessing Summit 2018
The Bioprocessing Summit, 13-17 August, Boston, convenes more than 1,000 international bioprocess professionals to share practical solutions for today's bioprocess challenges. Now in its tenth year, the event has grown to include 17 distinct conferences with weeklong programming on upstream and downstream processing, analytical development and quality, formulation and stability, cell and gene therapy production, and manufacturing. Along with the impressive array of conferences, the Summit also includes short courses and training seminars that provide in-depth coverage of critical bioprocess topics.
Read more...

Conference: 4th Annual Genome Editing UK Congress
Over 600 senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies. Over 20 case studies and presentations focused on the latest developments in gene editing techniques and case studies on the therapeutic applications of genome editing technologies.
Including 2 interactive streams: Genome Editing Techniques and Technologies, and Therapeutic Applications of Genome Editing.

The 4th Annual Genome Editing UK Congress, 8-9 November 2018, London, is co-located with the highly established 10th Annual Next Generation Sequencing and Clinical Diagnostics Congress, 6th Annual Single Cell Analysis Congress and the Synthetic Biology Congress.

Read more...

Conferences
- 16 - 19 May 2018, American Society of Gene and Cell Therapy (ASGCT) 21th Annual Meeting, Chicago, IL
- 5 - 6 June 2018, Advanced Therapy Medicinal Products Conference, Amsterdam, The Netherlands
- 15 - 20 June 2018, Monolith Summer School and Symposium (MSS) - Bioprocessing of macromolecules and viruses, Portorož, Slovenia
- 18 - 19 June 2018, International conference on Stem Cells and Regenerative Medicine - Genome editing for targeting genetic diseases, Osaka, Japan
- 27 - 28 June 2018, CAR-TCR Summit Asia, Singapore
- 23 - 24 July 2018, Annual Congress on Advanced Tissue Science and Regenerative Medicine, Rome, Italy
- 26 - 28 July 2018, The 24th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Tokyo, Japan
- 13 - 17 August 2018, Bioprocessing Summit 2018 - Gene Therapy, Boston, MA
- 4 - 7 September 2018, 4th Annual CAR-TCR Summit 2018, Boston, MA
- 10 - 11 September 2018, International Conference on Cell and Gene Therapy, Dublin, Ireland
- 16 – 19 October 2018, XXVI Congress of the European Society of Gene and Cell Therapy (ESGCT), Lausanne, Swizterland
- 24 – 25 October 2018, Annual Congress on CRISPR-Cas9 Technology, Boston, MA
- 25 – 26 October 2018, 4th Annual Cell & Gene Therapy Congress, London, UK
- 6-8 November 2018, World Orphan Drug Congress 2018, Barcelona, Spain
- 9-10 November 2018, 2nd Annual Summit on Cell Therapy and Stem Cell Research 2018 Conference, Atlanta, GA
- 23 November 2018, British Society for Gene and Cell Therapy (BSGCT) Annual Conference Autumn 2018, London, UK
- November 2018, 4th Annual Genome Editing UK Congress, London, UK
- 3 – 5 April 2019, 4th Spring school of the European Society of Gene and Cell Therapy (ESGCT), Naples, Italy
- 29 April - 2 May 2019, American Society of Gene and Cell Therapy (ASGCT) 22th Annual Meeting, Washington, DC
- 21 – 25 October 2019, XXVII Congress of the European Society of Gene and Cell Therapy (ESGCT), Barcelona, Spain

Read more...

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?